Estrogen receptor polymorphisms in tamoxifen-treated women with breast cancer

References

• Clemons M, Goss P. Estrogen and the risk of breast cancer. N Engl J Med 2001; 344: 276–285
   PubMed Web of Science ®Google Scholar
• Gold B, Kalush F, Bergeron J, Scott K, Mitra N, Wilson K, Ellis N, Huang H, Chen M, Lippert R, et al. Estrogen receptor genotypes and haplotypes associated with breast cancer risk. Cancer Res 2004; 64: 8891–1900
   PubMed Web of Science ®Google Scholar
• Fisher B, Costantino J P, Redmond C K, Fisher E R, Wickerham D L, Cronin W M. Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. J Natl Cancer Inst 1994; 86: 527–537
   PubMed Web of Science ®Google Scholar
• Early Breast Cancer Trialists' Collaborative Group. Tamoxifen for early breast cancer: an overview of the randomized trials. Lancet 1998; 351: 1451–1467
   PubMed Web of Science ®Google Scholar
• Kedar R P, Bourne T H, Powles T J, Collins W P, Ashley S E, Cosgrove D O, Campbell S. Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomized breast cancer prevention trial. Lancet 1994; 343: 1318–1321
   PubMed Web of Science ®Google Scholar
• Zhang H, McElrath T, Tong W, Pollard J W. The molecular basis of tamoxifen induction of mouse uterine epithelial cell proliferation. J Endocrinol 2003; 184: 129–140
   Google Scholar
• Hopp T A, Weiss H L, Parra I S, Cui Y, Osborne C K, Fuqua S A. Low levels of estrogen receptor β protein predict resistance to tamoxifen therapy in breast cancer. Clin Cancer Res 2004; 15: 7490–7499
   Google Scholar
• Cai Q, Shu X O, Jin F, Dai Q, Wen W, Cheng J R, Gao Y T, Zheng W. Genetic polymorphisms in the estrogen receptor α gene and risk of breast cancer: results from the Shanghai Breast Cancer Study. Cancer Epidemiol Biomark Prev 2003; 12: 853–859
   PubMed Web of Science ®Google Scholar
• Andersen T I, Heimdal K R, Skrede M, Tveit K, Berg K, Borresen A L. Oestrogen receptor (ESR) polymorphisms and breast cancer susceptibility. Hum Genet 1994; 94: 665–670
   PubMed Web of Science ®Google Scholar
• Wedren S, Lovmar L, Humphreys K, Magnusson C, Melhus H, Syvanen A C, Kindmark A, Landegren U, Fermer M L, Stiger F, et al. Oestrogen receptor α gene haplotype and postmenopausal breast cancer risk: a case control study. Breast Cancer Res 2004; 6: R437–R449
   PubMed Web of Science ®Google Scholar
• Mizunuma H, Hosoi T, Okano H, Soda M, Tokizawa T, Kagami I, Miyamoto S, Ibuki Y, Inoue S, Shiraki M, et al. Estrogen receptor gene polymorphism and bone mineral density at the lumbar spine of pre- and postmenopausal women. Bone 1997; 21: 379–383
   PubMed Web of Science ®Google Scholar
• Schuit S CE, van Meurs J BJ, Bergink A P, van der Klift M, Fang Y, Leusink G, Hofman A, van Leeuwen J P, Uitterlinden A G, Pols H A. Height in pre- and postmenopausal women is influenced by estrogen receptor α gene polymorphisms. J Clin Endocrinol Metab 2004; 89: 303–309
   PubMed Web of Science ®Google Scholar
• Zheng S L, Zheng W, Chang B L, Shu X O, Cai Q, Yu H, Dai Q, Xu J, Gao Y T. Joint effect of estrogen receptor β sequence variants and endogenous estrogen exposure on breast cancer risk in Chinese women. Cancer Res 2003; 15: 7624–7629
   Google Scholar
• Forsti A, Zhao C, Israelsson E, Dahlman-Wright K, Gustafsson J A, Hemminki K. Polymorphisms in the estrogen receptor β gene and risk of breast cancer: no association. Breast Cancer Res Treat 2003; 79: 409–413
   PubMedGoogle Scholar
• Georgiou I, Syrrou M, Bouba I, Dalkalitsis N, Paschopoulos M, Navrozoglou I, Lolis D. Association of estrogen receptor gene polymorphisms with endometriosis. Fertil Steril 1999; 72: 856–864
   Google Scholar
• Kitawaki J, Obayashi H, Ishihara H, Koshiba H, Kusuki I, Kado N, Tsukamoto K, Hasegawa G, Nakamura N, Honjo H. Oestrogen receptor-α gene polymorphism is associated with endometriosis, adenomyosis and leiomyomata. Hum Reprod 2001; 16: 51–55
   PubMed Web of Science ®Google Scholar
• Sundarrajan C, Liao W X, Roy A C, Ng S C. Association between estrogen receptor β gene polymorphisms and ovulatory dysfunction in patients with menstrual disorders. J Clin Endocrinol Metab 2001; 86: 135–139
   PubMed Web of Science ®Google Scholar